On the 10th of May 2016, the United States Patent and Trademark office issued an official document granting the US patent for Luer-Jack. The US Luer-Jack patent is an important part of the families of similar filed applications in all important markets world wide, and is a fundamental member of the Luer-Jack patent family.
The innovative Luer-Jack syringe is unique through the very simple one-hand operated disconnection function. Based on the leverage effect, the ‘Click and Release’ feature performs faster, safer and more efficient one-hand disconnections from needles and any other medical luer connections, and thereby reduces the risk of needlestick injuries. Using only one hand safeguards aseptic technique and could become a vital part of the on-going struggle to reduce the occurrence of hospital-acquired-infections.
US market entry – Luer-Jack
The US patent protection for Luer-Jack will further fuel the market introduction of Luer-Jack worldwide. Obtaining proper IPR protection in USA is fundamental to our planned US market entry.
‘ConceptoMed is serving the global market with innovative product categories and unique proprietary technology. This first US issued patent for Luer-Jack is an important milestone for ConceptoMed, for the global growth of the Luer-Jack concept – and ultimately for patient and healthcare worker safety in a growing and more complex world’, says Christian Mide, M.D., CEO and founder of ConceptoMed.
Background
The 6% taper friction fit (luer) connection is the most common connector type used in medical settings. Tapered fittings ensure tight connections by allowing female hubs to bond with male tips by friction fit. The simple design creates a strong hold. It was invented in the 1890’s and has been used predominantly in medical settings for over a century. However, both traditional luer slip and luer lock applications are disengaged using two hands for the operation – with fingers in close proximity with critical aseptic parts and sharp objects of medical procedures.
